These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. Yun KW; Kim HY; Park HK; Kim W; Lim IS J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288 [TBL] [Abstract][Full Text] [Related]
3. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089 [TBL] [Abstract][Full Text] [Related]
4. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Asadi Karam MR; Habibi M; Bouzari S Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763 [TBL] [Abstract][Full Text] [Related]
5. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection. He XL; Wang Q; Peng L; Qu YR; Puthiyakunnon S; Liu XL; Hui CY; Boddu S; Cao H; Huang SH Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25825479 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection. Habibi M; Asadi Karam MR; Bouzari S Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265 [TBL] [Abstract][Full Text] [Related]
7. Virulence factors of uropathogenic E. coli and their interaction with the host. Lüthje P; Brauner A Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the uropathogenic Escherichia coli surface proteome by tandem mass-spectrometry of artificially induced outer membrane vesicles. Wurpel DJ; Moriel DG; Totsika M; Easton DM; Schembri MA J Proteomics; 2015 Feb; 115():93-106. PubMed ID: 25534882 [TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. Donovan GT; Norton JP; Bower JM; Mulvey MA Infect Immun; 2013 Jan; 81(1):249-58. PubMed ID: 23115037 [TBL] [Abstract][Full Text] [Related]
10. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism. Su Q; Guan T; He Y; Lv H J Proteome Res; 2016 Apr; 15(4):1323-32. PubMed ID: 26954697 [TBL] [Abstract][Full Text] [Related]
11. Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat. Hibbing ME; Dodson KW; Kalas V; Chen SL; Hultgren SJ mBio; 2020 Sep; 11(5):. PubMed ID: 32994329 [TBL] [Abstract][Full Text] [Related]
12. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related]
13. A novel chaperone-effector-immunity system identified in uropathogenic Casiano González A; Pacheco Villanueva A; Castro-Alarcón N; Méndez J; Oropeza R; Martínez-Santos VI PeerJ; 2024; 12():e17336. PubMed ID: 38784397 [TBL] [Abstract][Full Text] [Related]
14. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118 [TBL] [Abstract][Full Text] [Related]
15. Quantification of bacteriuria caused by Hemolysin-positive Escherichia coli in human and mouse urine using quantitative polymerase chain reaction (qPCR) targeting hlyD. Chamoun MN; Sullivan MJ; Ulett GC J Microbiol Methods; 2018 Sep; 152():173-178. PubMed ID: 30110601 [TBL] [Abstract][Full Text] [Related]
16. 'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence. Lo AW; Moriel DG; Phan MD; Schulz BL; Kidd TJ; Beatson SA; Schembri MA Trends Microbiol; 2017 Sep; 25(9):729-740. PubMed ID: 28550944 [TBL] [Abstract][Full Text] [Related]
17. Pathogenomics of uropathogenic Escherichia coli. Agarwal J; Srivastava S; Singh M Indian J Med Microbiol; 2012; 30(2):141-9. PubMed ID: 22664427 [TBL] [Abstract][Full Text] [Related]
18. Urinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulence. Gawel D; Seed PC Virulence; 2011; 2(3):222-32. PubMed ID: 21597325 [TBL] [Abstract][Full Text] [Related]
19. Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli. Hirakawa H; Suzue K; Takita A; Kamitani W; Tomita H Infect Immun; 2021 May; 89(6):. PubMed ID: 33753414 [TBL] [Abstract][Full Text] [Related]
20. Fast identification of Escherichia coli in urinary tract infections using a virulence gene based PCR approach in a novel thermal cycler. Brons JK; Vink SN; de Vos MGJ; Reuter S; Dobrindt U; van Elsas JD J Microbiol Methods; 2020 Feb; 169():105799. PubMed ID: 31790780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]